DENNIS MULROY
CIK 1276840 · Chief Financial Officer · last filed 2026-05-07
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.37M
Companies
4
Total Filings
65
Lifetime Open-Market Net
-$2.29M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ARCT | Chief Financial Officer | — | $6.97 | — | $0 | 1 | 2026-05-07 |
| ANAB | CHIEF FINANCIAL OFFICER | 24,367 | $56.07 | $1.37M | -$2.31M | 20 | 2026-01-09 |
| LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Chief Financial Officer | 5,067 | $6.22 | $31.5K | $17.0K | 42 | 2020-06-02 |
| CXM | Chief Financial Officer | — | $5.34 | — | $0 | 1 | 2009-03-17 |
Recent Filings · Page 3 of 7
65 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-07-15 | ANAB | Grant (A) | — | $0 | EDGAR |
| 2020-06-02 | LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Grant (A) | +82 | $329 | EDGAR |
| 2020-05-19 | LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Grant (A) | +56 | $328 | EDGAR |
| 2020-05-04 | LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Grant (A) | +53 | $327 | EDGAR |
| 2020-04-17 | LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Grant (A) | +58 | $325 | EDGAR |
| 2020-01-13 | LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-01-03 | LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Grant (A) | +16 | $53 | EDGAR |
| 2019-12-17 | LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Grant (A) | +112 | $319 | EDGAR |
| 2019-12-03 | LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Grant (A) | +138 | $322 | EDGAR |
| 2019-11-19 | LA JOLLA PHARMACEUTICAL CO (LJPC) Delisted | Grant (A) | +62 | $317 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.